Literature DB >> 27667135

Prevention of bronchiolitis obliterans-the realization of a hope?

Marilia Cascalho1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27667135      PMCID： PMC6064646          DOI： 10.1016/j.healun.2016.08.001

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  6 in total

1.  Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation.

Authors:  Navneet S Majhail; Charles A Schiffer; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2006-07       Impact factor: 5.742

2.  Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  S Watanabe; Y Waseda; H Kimura; H Takato; K Ohata; Y Kondo; K Kasahara; S Nakao
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

Review 3.  Obliterative bronchiolitis.

Authors:  Alan F Barker; Anne Bergeron; William N Rom; Marshall I Hertz
Journal:  N Engl J Med       Date:  2014-05-08       Impact factor: 91.245

4.  Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.

Authors:  Yoshinori Aono; Yasuhiko Nishioka; Mami Inayama; Momoyo Ugai; Jun Kishi; Hisanori Uehara; Keisuke Izumi; Saburo Sone
Journal:  Am J Respir Crit Care Med       Date:  2005-02-25       Impact factor: 21.405

5.  Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

Authors:  Craig E Daniels; Mark C Wilkes; Maryanne Edens; Ted J Kottom; Stephen J Murphy; Andrew H Limper; Edward B Leof
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation.

Authors:  Satoshi Watanabe; Kazuo Kasahara; Yuko Waseda; Hazuki Takato; Shingo Nishikawa; Taro Yoneda; Johsuke Hara; Takashi Sone; Miki Abo; Hideharu Kimura; Shinji Nakao
Journal:  J Heart Lung Transplant       Date:  2016-06-03       Impact factor: 10.247
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.